About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Longitudinal PTH-Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03464149

The Longitudinal PTH-Study

The main study aim is to quantify the agreement between the analytical results provided by two third generation and two second generation Parathyroid hormone (PTH) assays. The primary comparison will ...

Lead sponsor: Medical University of Vienna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Medical University of Vienna

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All patients who were undergoing uninterrupted hemodialysis or hemodiafiltration at the Chronic Hemodialysis Unit of the Division of Nephrology and Dialysis, Medical University of Vienna between November 1st, 2017 and December 31st, 2018.
•Existence of residual blood samples from four successive quarterly routine controls
•Age ≥ 18 years
•The test result of the assay must not have any diagnostic value or therapeutic consequence for the patients included in this study.

Exclusion Criteria

•Death during the observational period (all patients must have lived through the 1-year period and must have all 4 quarterly blood draws performed on them).
•Age \<18 years

Related studies

RECRUITINGPhase 3

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

NCT03633708 · Secondary Hyperparathyroidism, Chronic Kidney Disease

Kidney Perfusion With or Without Absorption

NCT06374121 · Kidney Replacement

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

NCT04922892 · Secondary Hyperparathyroidism;Parathyroidectomy

COMPLETEDPhase 3

The Trial of SHR6508 in Secondary Hyperparathyroidism

NCT06434961 · Secondary Hyperparathyroidism

TERMINATEDPhase 3

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

NCT04064827 · Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism (SHPT)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 25, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment132

Start dateMar 2018

Last updatedJun 25, 2020

Condition

CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder Secondary Hyperparathyroidism Kidney Replacement

Locations shown

Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 25, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions